136 related articles for article (PubMed ID: 1722861)
1. Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency.
ten Brink HJ; Wanders RJ; Stellaard F; Schutgens RB; Jakobs C
J Inherit Metab Dis; 1991; 14(3):345-8. PubMed ID: 1722861
[No Abstract] [Full Text] [Related]
2. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
3. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
4. Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.
ten Brink HJ; Poll-The BT; Saudubray JM; Wanders RJ; Jakobs C
J Inherit Metab Dis; 1991; 14(5):681-4. PubMed ID: 1779614
[TBL] [Abstract][Full Text] [Related]
5. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid alpha-oxidase deficiency (Refsum disease) presenting in infancy.
Herbert MA; Clayton PT
J Inherit Metab Dis; 1994; 17(2):211-4. PubMed ID: 7526031
[TBL] [Abstract][Full Text] [Related]
8. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
9. Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case report.
Wanders RJ; Boltshauser E; Steinmann B; Spycher MA; Schutgens RB; van den Bosch H; Tager JM
J Neurol Sci; 1990 Aug; 98(1):1-11. PubMed ID: 1700075
[TBL] [Abstract][Full Text] [Related]
10. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.
Poll-The BT; Saudubray JM; Ogier H; Schutgens RB; Wanders RJ; Schrakamp G; van den Bosch H; Trijbels JM; Poulos A; Moser HW
J Inherit Metab Dis; 1986; 9(2):169-74. PubMed ID: 2427795
[TBL] [Abstract][Full Text] [Related]
11. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
12. A new peroxisomal disorder: di- and trihydroxycholestanaemia due to a presumed trihydroxycholestanoyl-CoA oxidase deficiency.
Christensen E; Van Eldere J; Brandt NJ; Schutgens RB; Wanders RJ; Eyssen HJ
J Inherit Metab Dis; 1990; 13(3):363-6. PubMed ID: 2122101
[No Abstract] [Full Text] [Related]
13. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
[TBL] [Abstract][Full Text] [Related]
15. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
Poulos A; Sharp P; Fellenberg AJ; Danks DM
Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
[TBL] [Abstract][Full Text] [Related]
16. The segregation of glutaryl-CoA dehydrogenase deficiency and Refsum syndrome in a family.
Christensen E; Brandt NJ; Rosenberg T; Bömers K; Jakobs C
J Inherit Metab Dis; 1994; 17(3):287-90. PubMed ID: 7528828
[No Abstract] [Full Text] [Related]
17. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children.
Budden SS; Kennaway NG; Buist NR; Poulos A; Weleber RG
J Pediatr; 1986 Jan; 108(1):33-9. PubMed ID: 2418187
[TBL] [Abstract][Full Text] [Related]
18. An improved method for quantification of very long chain fatty acids in plasma.
Vallance H; Applegarth D
Clin Biochem; 1994 Jun; 27(3):183-6. PubMed ID: 7522996
[TBL] [Abstract][Full Text] [Related]
19. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
20. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
